- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
GlaxoSmithKline Pharma's board authorized its MD, CFO, CS, and Legal Head to collectively identify key company events for stock market disclosure. This operational change improves transparency and governance for investor updates.
All announcements from GlaxoSmithKline Pharmaceuticals Limited